Unlikely to cause harm — often a labeling or packaging issue.
Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.
| Brand name | AZACITIDINE |
| Generic name | AZACITIDINE |
| Active ingredient(s) | AZACITIDINE |
| Distributed by / for | Teva Pharmaceuticals USA Inc |
| NDC | 68001-313-56 |
| Full product label | Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56 |
| Recalling firm | Teva Pharmaceuticals USA Inc |
| Distribution | Distributed in Ohio |
| Quantity | 4162 cartons |
| Recall initiated | 2022-07-22 |
| Report date | 2022-08-17 |
| Recall completed | 2023-04-12 |
| Recall number | D-1334-2022 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗